Seeking Alpha

Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have...

Johnson & Johnson's (JNJ +2.5%) subsidiary Cordis says European regulators and the FDA have approved additional sizes for the company's Sleek OTW platform, an ultra-low profile percutaneous transluminal angioplasty dilatation catheter. The device is a highly deliverable balloon catheter designed to treat patients undergoing peripheral angioplasty procedures below the knee.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs